DE69619187D1 - Verfahren zur behandlung von motorischen defiziten - Google Patents

Verfahren zur behandlung von motorischen defiziten

Info

Publication number
DE69619187D1
DE69619187D1 DE69619187T DE69619187T DE69619187D1 DE 69619187 D1 DE69619187 D1 DE 69619187D1 DE 69619187 T DE69619187 T DE 69619187T DE 69619187 T DE69619187 T DE 69619187T DE 69619187 D1 DE69619187 D1 DE 69619187D1
Authority
DE
Germany
Prior art keywords
deficites
treating engine
treating
engine
deficit symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69619187T
Other languages
English (en)
Other versions
DE69619187T2 (de
Inventor
John Mcmichael
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Milkhaus Laboratory Inc
Original Assignee
Milkhaus Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milkhaus Laboratory Inc filed Critical Milkhaus Laboratory Inc
Application granted granted Critical
Publication of DE69619187D1 publication Critical patent/DE69619187D1/de
Publication of DE69619187T2 publication Critical patent/DE69619187T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
DE69619187T 1995-04-13 1996-03-13 Verfahren zur behandlung von motorischen defiziten Expired - Lifetime DE69619187T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/421,231 US5576289A (en) 1995-04-13 1995-04-13 Methods for treating motor deficits
PCT/US1996/003456 WO1996032125A1 (en) 1995-04-13 1996-03-13 Methods for treating motor deficits

Publications (2)

Publication Number Publication Date
DE69619187D1 true DE69619187D1 (de) 2002-03-21
DE69619187T2 DE69619187T2 (de) 2002-10-31

Family

ID=23669709

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69619187T Expired - Lifetime DE69619187T2 (de) 1995-04-13 1996-03-13 Verfahren zur behandlung von motorischen defiziten

Country Status (8)

Country Link
US (1) US5576289A (de)
EP (1) EP0769957B1 (de)
JP (1) JP2885517B2 (de)
AT (1) ATE213163T1 (de)
AU (1) AU686051B2 (de)
CA (1) CA2192675C (de)
DE (1) DE69619187T2 (de)
WO (1) WO1996032125A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
AU2004206971B8 (en) * 1997-03-04 2010-10-07 Milkhaus Laboratory, Inc. Method of treatment of conditions by administration of streptolysin O
US5736508A (en) * 1997-03-04 1998-04-07 Milkhaus Laboratory, Inc. Methods for treatment of scar tissue
US6303127B1 (en) 1997-03-04 2001-10-16 Milkhaus Laboratory, Inc. Treatment of disease states
US6998121B2 (en) * 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
US7629312B2 (en) 2003-01-23 2009-12-08 Milkhaus Laboratory, Inc. Method of treatment of tendonitis by administration of streptolysin O
US20100144602A1 (en) * 2003-01-23 2010-06-10 Milkhaus Laboratory, Inc. Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O
US20080182789A1 (en) * 2007-01-30 2008-07-31 Milkhaus Laboratory, Inc. Method of treating pulmonary fibrosis
US20140120191A1 (en) 2011-05-16 2014-05-01 Beech Tree Labs Inc. Method of treating a disorder associated with sequestered bacteria
EP2819690A4 (de) 2012-02-27 2016-07-06 Beech Tree Labs Inc Verfahren zur behandlung der chronisch obstruktiven lungenkrankheit
JP2018510895A (ja) 2015-04-08 2018-04-19 ビーチ ツリー ラボ、インコーポレイテッド 外傷性脳損傷を治療する方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992015327A1 (en) * 1991-03-08 1992-09-17 Protein Design Labs, Inc. Recombinant double chain immunotoxins
US5378620A (en) * 1991-08-30 1995-01-03 Beckman Instruments, Inc. Streptolysin O derivatives
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
AU6098194A (en) * 1993-01-29 1994-08-15 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof

Also Published As

Publication number Publication date
EP0769957A4 (de) 1999-11-03
EP0769957B1 (de) 2002-02-13
CA2192675A1 (en) 1996-10-17
JP2885517B2 (ja) 1999-04-26
DE69619187T2 (de) 2002-10-31
AU686051B2 (en) 1998-01-29
AU5252196A (en) 1996-10-30
JPH09509968A (ja) 1997-10-07
ATE213163T1 (de) 2002-02-15
CA2192675C (en) 2002-05-28
US5576289A (en) 1996-11-19
WO1996032125A1 (en) 1996-10-17
EP0769957A1 (de) 1997-05-02

Similar Documents

Publication Publication Date Title
DE60027732D1 (de) Verwendung von anti-rubeola antkörpern zur behandlung von symptomen von erkrankungen des zentralen nervensystems
ATE266417T1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
DE69609868T2 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
ATE522229T1 (de) Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
DE3855525T2 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
DE69710422T2 (de) Verfahren zur Behandlung von Polyethern vor Hydrosilylation
DE69008820D1 (de) Verfahren zur Behandlung von Polymerisaten.
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
ATE400301T1 (de) Arteriovenöse und venöse transplantatbehandlungen: methoden und zusammensetzungen
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
DE69619187T2 (de) Verfahren zur behandlung von motorischen defiziten
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
ATE368110T1 (de) Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten
ATE484294T1 (de) Anti-interleukin-9 antikörper oder anti- interleukin-9 rezeptor antikörper zur behandlung von bronchialem hyperreaktionsvermögen
DE3587681T2 (de) Vakzine und Serum für Endotoxin assoziierte Krankheit und Verfahren zur Herstellung derselben sowie Verfahren zur Immunisierung und Behandlung solcher Krankheiten, enttoxifierte Endotoxine und bakterielle Mutante.
DE69936994D1 (de) Verfahren zur behandlung von okularen neovaskularen erkrankungen
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69607559D1 (de) Verfahren zur Behandlung von Phenolteer
DE69102294T2 (de) Verfahren zur Behandlung von Abgasen, die ClF3 enthalten.
DE60144493D1 (de) Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
DE59102745D1 (de) Verfahren une einrichtung zur behandlung von saatgut.
DE69820580D1 (de) Verfahren zur Abtrennung von Metallen durch micellare Ultrafiltration, geeignet zur Behandlung von radioaktiven Abfallstoffen
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
DE3775426D1 (de) Verfahren zur behandlung von gasoelen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition